Detection of brain tau pathology in Down syndrome using plasma biomarkers

Authors

Shorena Janelidze, Lund University
Bradley T Christian, University of Wisconsin-Madison
Julie Price, Harvard University
Charles Laymon, University of Pittsburgh
Nicole Schupf, Columbia University
William E Klunk, University of Pittsburgh
Ira Lott, University of California, Irvine
Wayne Silverman, University of California, Irvine
H Diana Rosas, Harvard University
Shahid Zaman, University of Cambridge
Mark Mapstone, University of California, Irvine
Florence Lai, Harvard University
Beau M Ances, Washington University School of Medicine in St. Louis
Benjamin L Handen, University of Pittsburgh
Oskar Hansson, Lund University

Journal

JAMA Neurology

Publication Date

8-1-2022

Volume

79

Issue

8

First Page

797

Last Page

807

Document Type

Open Access Publication

DOI

10.1001/jamaneurol.2022.1740

Rights and Permissions

Janelidze S, Christian BT, Price J, et al. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers. JAMA Neurol. 2022;79(8):797–807. doi:10.1001/jamaneurol.2022.1740. This is an open access article distributed under the terms of the CC-BY License. © 2022 Janelidze S et al. JAMA Neurology.

Recommended Citation

Janelidze, Shorena; Christian, Bradley T; Price, Julie; Laymon, Charles; Schupf, Nicole; Klunk, William E; Lott, Ira; Silverman, Wayne; Rosas, H Diana; Zaman, Shahid; Mapstone, Mark; Lai, Florence; Ances, Beau M; Handen, Benjamin L; and Hansson, Oskar, "Detection of brain tau pathology in Down syndrome using plasma biomarkers." JAMA Neurology. 79, 8. 797 - 807. (2022).
https://digitalcommons.wustl.edu/oa_4/4549

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.